Johnson & Johnson said on Aug. 27 that the interleukin‑23 receptor antagonist Aiteya (Yikebaizhisu hydrochloride tablets) has been approved by China’s National Medical Products Administration for adults with moderate‑to‑severe plaque psoriasis eligible for systemic therapy or phototherapy, and for children aged 12 and older weighing at least 40 kg.

China’s Ministry of Industry and Information Technology and three other departments have launched a special campaign to boost road-vehicle production consistency and quality. Local MIIT authorities must lead comprehensive self-inspection and rectification of key vehicle makers against access-management rules and priority remediation items, including production consistency, reliability, durability, testing and validation of new technologies, and key-parts supplier issues. Automakers must submit self-inspection and rectification reports to local industry authorities by end‑December 2026. Firms that identify defects must file recall plans with the State Administration for Market Regulation and proactively implement recalls. Local industry departments are to enforce responsibilities, tighten supply-chain management and production-consistency controls, and require strengthened testing/validation of aggressive innovation designs, full safety-risk assessment, and prudent on-vehicle deployment of new technologies.

英伟达(NVDA.O)首席财务官：我们已经向前沿AI实验室投资了500亿美元。